IP Library Granted Patent US 8,475,828
Granted Patent B2
US 8,475,828 · App. 13/238,459 · Granted Jul 2, 2013

Medical apparatus and method for producing same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,475,828
App. No.
13/238,459
Granted
Jul 2, 2013
Kind
B2
Abstract

A medical device that includes at least one antibiotic in a macromolecular substance that swells upon contact with a solvent. Also, a method for preparing an antibiotic-containing medical device that involves contacting a medical device having at least a portion of the surface formed from a swellable macromolecular substance, with a solvent that swells the macromolecular substance, contacting the swollen macromolecular substance with at least one antibiotic, and removing the solvent from the swollen macromolecular substance.

Claims (9)

1. A method for preparing an antibiotic-containing medical device comprising:

providing a medical device having at least a portion of the surface formed from a swellable macromolecular substance; swelling said macromolecular substance by contacting it with an aprotic polar solvent; then contacting the swollen macromolecular substance with at least one water-soluble antibiotic dissolved in an aqueous solution; and removing residual solvent.

2. The method of claim 1 wherein the medical device comprises a synthetic resin.

3. The method of claim 2 wherein the synthetic resin is selected from the group consisting of a polyurethane, a polyamide, and combinations thereof.

4. The method of claim 1 wherein the aprotic polar solvent is selected from the group consisting of dimethylformamide, dimethyl sulphoxide, dimethylacetamide, 2-butanone, acetone, acetonitrile, N-methylpyrrolidone, and combinations thereof.

5. The method of claim 1 wherein the water soluble antibiotic is selected from the group consisting of isepamicin sulphate, amikacin sulphate, tobramycin, kitasamycin tartrate, and combinations thereof.

6. The method of claim 1 , wherein the antibiotic is retained within the macromolecular substance.

7. The method of claim 1 , wherein at least a portion of the macromolecular substance comprises a meshwork structure, and the antibiotic is retained in said meshwork structure.

8. The method of claim 1 wherein the solvent is removed from the swollen macromolecular substance by a method selected from the group consisting of drying, washing, and combinations thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2017
From: COVIDIEN LP
To: KPR U.S., LLC
Reel/Frame 044118/0652 →